Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam purchased 607 shares of the business's stock in a transaction on Wednesday, July 9th. The stock was bought at an average cost of GBX 50 ($0.67) per share, with a total value of £303.50 ($407.49).
Jayne Cottam also recently made the following trade(s):
- On Tuesday, May 6th, Jayne Cottam purchased 306 shares of Assura stock. The shares were purchased at an average cost of GBX 49 ($0.66) per share, with a total value of £149.94 ($201.32).
Assura Price Performance
Shares of Assura stock traded up GBX 0.31 ($0.00) during trading on Monday, hitting GBX 50.29 ($0.68). 10,755,535 shares of the stock traded hands, compared to its average volume of 29,115,318. The stock has a market cap of £1.64 billion, a price-to-earnings ratio of -48.07, a PEG ratio of 3.60 and a beta of 0.37. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. Assura Plc has a 52 week low of GBX 35.24 ($0.47) and a 52 week high of GBX 50.95 ($0.68). The firm's fifty day moving average is GBX 49.55 and its 200-day moving average is GBX 44.97.
Assura Company Profile
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Read More

Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.